The Northern Ophthalmic Research and Innovation (NORI) hub at Sunderland University has been awarded £12.2m through UK Research and Innovation (UKRI) to develop artificial intelligence that reads routine eye scans for early signals of illness, the BBC reports. The funding, announced as part of a government push behind the project, is intended to help diagnose patients sooner. Science minister Chris McDonald visited the hub on Thursday.
The tool will begin with diabetes and cardiovascular disease. According to the BBC, the team believes the same approach could later be extended to conditions such as dementia and strokes.
Why it matters
The back of the eye holds very small blood vessels and nerve tissue, and NORI says these structures can carry clues about a person's broader health before any symptoms show up. If the technology works as intended, a test that patients already take could double as an early warning system for conditions that are often caught late.
McDonald framed the investment in terms of pressure on the health service. Diagnosing sooner, he said, leads to better results for patients and eases the load on the NHS, and he argued that technology has an important part to play in that. The BBC reports his comments from the visit.
The money also has an economic dimension. Matthew Campbell, interim pro vice-chancellor for health and co-director of NORI, said the award gives the team room to build the technology and then bring it to markets outside the UK. In his words, the funding establishes a fresh health innovation ecosystem for the North East, giving researchers the scale to develop tools, try them in real clinical settings and sell them nationally and internationally.
How the system is meant to work
The AI will examine eye scans taken during ordinary appointments, the kind of imaging already carried out in routine care. It will then cross-reference what it finds against NHS health records and community data, looking for faint patterns that might point to disease in its earliest stages. The aim is to surface changes that a human reviewer might not notice, or might not have time to look for.
NORI is one of five healthcare hubs backed by UKRI that are applying technology to diagnosis. The others are in Exeter, Southampton and London, and all of them are working on high-tech tools, according to the BBC. Sunderland's distinct angle is the eye as a window into systemic health, paired with the data holdings of the NHS.
Campbell's remarks suggest the project is not purely a laboratory exercise. The stated goal is to test the technology in real-world healthcare settings, which means the path from research to clinical use runs through the same system it is meant to support.
What to watch is whether the diabetes and cardiovascular work produces results solid enough to justify expanding into dementia and stroke detection, and how quickly the team moves from testing in North East settings toward the national and international markets Campbell described.
